Narcotic antagonist
FR: Reversal of respiratory depression caused by suspected narcotic intoxication
FR: Reversal of respiratory depression caused by suspected narcotic intoxication
EMR: Reversal of respiratory depression caused by suspected narcotic intoxication
Naloxone IM every 3 minutes as required; maximum 4 doses
PCP: Reversal of respiratory depression caused by suspected narcotic intoxication
Naloxone IM/IV every 3 minutes as required; maximum 4 doses
*Palliative patient populations: titrating 0.1mg IM/IV/min for opioid overdose in the palliative patient to reverse respiratory depression without interfering with pain contro
ACP: Reversal of respiratory depression caused by suspected narcotic intoxication
Titrate doses to improve spontaneous respiratory effort and minimize withdrawal symptoms.
Never administer naloxone to neonates
FR: Not authorized for use in pediatrics
EMR: Reversal of respiratory depression caused by suspected narcotic intoxication
Competitively antagonizes opioids bound to receptors in the central nervous system.
Some evidence exists that suggests naloxone may be heat sensitive, losing some potency after 4+ weeks of storage at temperatures consistently above 40°C. Degraded medication is unlikely to be harmful to patients, but may not carry the same clinical effects, thus requiring higher doses.